The unique market dynamics in Michigan have contributed to lower hospital prices, but it remains to be seen if recent policy changes will reveal these prices to be artificially depressed, according to Bret Jackson, president of the Economic Alliance for Michigan.
The unique market dynamics in Michigan have contributed to lower hospital prices, but it remains to be seen if recent policy changes will reveal these prices to be artificially depressed, according to Bret Jackson, president of the Economic Alliance for Michigan.
Transcript
In the RAND study comparing hospital prices for privately insured patients to a Medicare benchmark, Michigan’s prices were among the lowest of the states studied and they actually fell during the study timeframe. To what do you attribute that success?
So there’s a number of market dynamics in Michigan that I think contributed to our lower prices. We have a relatively dominant carrier in Michigan, the Blue Cross Blue Shield of Michigan plan, we have Medicaid expansion, certificate of need, we have a relatively low uninsured rate, and so I think all of these things contributed to low prices.
But at the same time, the Michigan legislature just changed the auto no-fault insurance law. The auto insurance companies had been paying charges on an unlimited benefit for a period of time, and that may artificially depress prices. So now that the change is made just a month or so ago, we can see if prices were artificially low and if those prices will change as hospitals try to recoup revenue lost from the auto insurance change.
In VERIFY, Rusfertide Spares Most Patients With PV a Phlebotomy for 32 Weeks, Improves QOL
June 3rd 2025Adding rusfertide to standard of care more than doubled the share of patients with polycythemia vera (PV) who did not meet criteria for a phlebotomy, according to data from the VERIFY trial.
Read More
Mental Health Awareness: Transforming Workplace Support and Engagement
May 20th 2025Explore how employers enhance workplace mental health by fostering a culture of support and engagement, focusing on holistic well-being strategies in this interview with Jim Kinville, MA, University of Pittsburgh Medical Center.
Listen
Depth of Responses, PFS in Transplant-Ineligible Patients Match Overall Findings in CEPHEUS
June 2nd 2025Quadruplet therapy is now the accepted standard for patients newly diagnosed with myeloma who are ineligible for transplant; there is debate whether all newly diagnosed patients should have this regimen.
Read More
Multicancer Detection Assays Remain Largely Elusive for Early-Stage Disease Detection
June 1st 2025Multicancer early detection tests are revolutionizing cancer screening by using liquid biopsies to screen for multiple cancers from a single blood sample, enhancing patient outcomes by identifying cancers earlier.
Read More